CRISPR Therapeutics (CRSP) Reiterated at Market Outperform by Citizens
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| (NASDAQ: CRSP) | Delayed: 49.99 -0.51 (1.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $50.50 | 52 Week High | $18.88 | |||
| Open | $49.89 | 52 Week Low | $13.75 | |||
| Day High | $51.05 | P/E | N/A | |||
| Day Low | $49.36 | EPS | $0.00 | |||
| Volume | 905,975 | |||||
